WikiMD is the world's largest medical encyclopedia with
13,948 pages, 4,144,396 edits & 41,644,046 views.
111In-ibritumomab tiuxetan
(... ih-brih-TOO-moh-mab ty-UK-seh-tan) A radiolabeled monoclonal antibody used to find certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the diagnosis of other types of B-cell tumors. 111In-ibritumomab tiuxetan is made up of the monoclonal antibody ibritumomab plus the radioisotope indium In 111. It binds to a protein called CD20, which is found on B cells. A machine is used to find which cells in the body have taken up 111In-ibritumomab tiuxetan. 111In-ibritumomab tiuxetan is a type of radioimmunoconjugate. Also called 111In-Zevalin and indium In 111-ibritumomab tiuxetan.
/ ===External links===
This WikiMD article 111In-ibritumomab tiuxetan is a stub. If you are familiar with the topic 111In-ibritumomab tiuxetan, you can help us. Paid editors welcome!
111In-ibritumomab tiuxetan is part of WikiMD's free ^articles!
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
 Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available |
